Telix Pharmaceuticals Ltd Files AGM Results
Ticker: TLPPF · Form: 6-K · Filed: May 21, 2025 · CIK: 2007191
| Field | Detail |
|---|---|
| Company | Telix Pharmaceuticals Ltd (TLPPF) |
| Form Type | 6-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, filing-update
TL;DR
Telix Pharmaceuticals filed its AGM results on 5/21/25 - check for updates.
AI Summary
On May 21, 2025, Telix Pharmaceuticals Limited filed three announcements with the Australian Securities Exchange regarding its Annual General Meeting. These included the Chairman and CEO addresses, a presentation, and the results of the meeting. The company is incorporated in Australia and its principal executive offices are located in North Melbourne.
Why It Matters
This filing provides shareholders with updates on the company's performance and strategic direction as presented at the Annual General Meeting.
Risk Assessment
Risk Level: low — This is a routine filing of meeting results and does not introduce new financial or operational risks.
Key Players & Entities
- Telix Pharmaceuticals Limited (company) — Registrant
- May 21, 2025 (date) — Filing date
- Australian Securities Exchange (company) — Exchange where announcements were filed
FAQ
What specific announcements were filed by Telix Pharmaceuticals Limited on May 21, 2025?
Telix Pharmaceuticals Limited filed three announcements: 'Telix Annual General Meeting Chairman and CEO Addresses,' 'Telix Annual General Meeting Presentation,' and 'Telix Results of'.
What is the Commission File Number for Telix Pharmaceuticals Limited?
The Commission File Number for Telix Pharmaceuticals Limited is 001-42128.
Where are Telix Pharmaceuticals Limited's principal executive offices located?
Telix Pharmaceuticals Limited's principal executive offices are located at 55 Flemington Road, North Melbourne, Victoria 3051, Australia.
Under which SEC Act is this Form 6-K filed?
This Form 6-K is filed pursuant to the 1934 Act.
Does Telix Pharmaceuticals Limited file annual reports under Form 20-F or Form 40-F?
Telix Pharmaceuticals Limited indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding Telix Pharmaceuticals Ltd (TLPPF).